[go: up one dir, main page]

CN115212354A - Bone repair stent with gradient coating and preparation method thereof - Google Patents

Bone repair stent with gradient coating and preparation method thereof Download PDF

Info

Publication number
CN115212354A
CN115212354A CN202210039664.3A CN202210039664A CN115212354A CN 115212354 A CN115212354 A CN 115212354A CN 202210039664 A CN202210039664 A CN 202210039664A CN 115212354 A CN115212354 A CN 115212354A
Authority
CN
China
Prior art keywords
coating
solution
stent
gradient
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210039664.3A
Other languages
Chinese (zh)
Inventor
沈理达
何志静
张寒旭
焦晨
吴俊男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Aeronautics and Astronautics
Original Assignee
Nanjing University of Aeronautics and Astronautics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Aeronautics and Astronautics filed Critical Nanjing University of Aeronautics and Astronautics
Priority to CN202210039664.3A priority Critical patent/CN115212354A/en
Publication of CN115212354A publication Critical patent/CN115212354A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/46Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • A61L27/306Other specific inorganic materials not covered by A61L27/303 - A61L27/32
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow
    • A61L2300/604Biodegradation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings
    • A61L2300/608Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to the technical field of medical materials, and particularly discloses a bone repair stent with a gradient coating and a preparation method thereof. The bone repair scaffold comprises a porous ceramic matrix and a polymer coating on the surface of the porous ceramic matrix, wherein the polymer coating loads trace elements in a gradient concentration mode, and the trace elements are selected from one or more of magnesium, zinc, copper, calcium, strontium and iron. According to the invention, the multi-layer polymer coating is coated on the basis of the porous ceramic support, so that the strength and toughness of the porous ceramic support are improved, and meanwhile, the polymer coating has certain swelling property after being implanted, and can play a role in stabilizing the support. Wherein, the microelements with special functions are doped in the polymer coating in the form of ionic crosslinking. Furthermore, the concentration of the trace elements is controlled to be changed from the outer layer to the inner layer of the coating in a gradient manner in a multi-layer coating manner, so that the trace elements with different concentrations or different types can be released at different periods after the stent is implanted, and the actual requirements of a human body can be met.

Description

一种具有梯度涂层的骨修复支架及其制备方法Bone repair scaffold with gradient coating and preparation method thereof

技术领域technical field

本发明涉及医用材料技术领域,具体涉及一种具有梯度涂层的骨修复支架及其制备方法。The invention relates to the technical field of medical materials, in particular to a bone repair bracket with a gradient coating and a preparation method thereof.

背景技术Background technique

骨骼作为人体最重要的器官之一,本身具备一定的自修复能力,但对于超过临界尺寸的骨缺损则必须配合适当的骨替代材料辅助治疗。在传统骨修复材料无法满足治疗需求的背景下,人们迫切期望找到一种性能优良的人工骨修复材料来解决目前的困境。目前主流的人工骨修复材料有金属材料、生物陶瓷、高分子材料、复合材料等。其中生物陶瓷,凭借其良好的生物相容性、一定的降解性以及潜在的骨传导和骨诱导性成为研究的热点。As one of the most important organs of the human body, bone has a certain self-healing ability, but for bone defects exceeding the critical size, it must be treated with appropriate bone substitute materials. Under the background that traditional bone repair materials cannot meet the treatment needs, it is urgent to find an artificial bone repair material with excellent performance to solve the current predicament. At present, the mainstream artificial bone repair materials include metal materials, bioceramics, polymer materials, and composite materials. Among them, bioceramics have become a research hotspot due to their good biocompatibility, certain degradability, and potential osteoconduction and osteoinduction.

通常,用于骨修复的生物材料要求具有三维多孔结构,贯通的多孔结构不仅为新生骨组织和血管提供长入空间,还可以作为营养物质和代谢产物的运输通道,同时研究表明孔径尺寸大于300μm的骨支架还可以促进血管的生长。增材制造,又名3D打印技术,因其在高精度、个性化制造以及在复杂形状构建上的独特优势,近些年来发展迅猛,并逐渐融入各行各业,其中基于DLP的光固化成形技术以精度高、成形快的优势成为生物陶瓷骨支架制备的首选。Generally, biomaterials used for bone repair require a three-dimensional porous structure. The through-hole porous structure not only provides space for new bone tissue and blood vessels to grow into, but also acts as a transport channel for nutrients and metabolites. At the same time, studies have shown that the pore size is greater than 300 μm The bone scaffold can also promote the growth of blood vessels. Additive manufacturing, also known as 3D printing technology, has developed rapidly in recent years due to its unique advantages in high-precision, personalized manufacturing and complex shape construction, and has gradually integrated into all walks of life. Among them, DLP-based light curing forming technology With the advantages of high precision and fast forming, it has become the first choice for the preparation of bioceramic bone scaffolds.

可降解生物聚合物材料因其良好的生物相容性以及与人体组织极高的亲和力,很早就被发现并尝试应用于组织工程领域,但有限的力学性能限制了它的发展,目前,常作为涂层材料应用于骨修复材料的表面改性。在陶瓷支架表面涂覆一层聚合物材料,可以在一定程度上增强陶瓷支架的强度和韧性,在植入人体后,还会产生一定的溶胀,起到稳定支架的作用,避免无菌性感染炎症的发生。此外,还可以作为药物递送的载体,赋予支架一定的功能性。但聚合物材料作为一种凝胶状的材料,如何有效地涂覆在陶瓷支架表面,同时不影响支架的孔隙结构,成为影响聚合物涂层应用的关键技术难点。Due to its good biocompatibility and high affinity with human tissues, degradable biopolymer materials have been discovered and tried to be applied in the field of tissue engineering for a long time, but limited mechanical properties limit its development. It is used as a coating material for surface modification of bone repair materials. Coating a layer of polymer material on the surface of the ceramic stent can enhance the strength and toughness of the ceramic stent to a certain extent. After implanting in the human body, it will also swell to a certain extent, which can stabilize the stent and avoid aseptic infection. occurrence of inflammation. In addition, it can also be used as a carrier for drug delivery to endow the stent with certain functionality. However, as a gel-like material, how to effectively coat the surface of the ceramic stent without affecting the pore structure of the stent has become a key technical difficulty affecting the application of polymer coatings.

术后感染是导致植入手术失败最主要的原因之一,在过去的几十年中,抗生素的滥用导致菌株突变,由抗生素耐药性导致的手术失败案例逐年增长。研究人员发现部分金属阳离子,如Ag+、Mg2+、Zn2+和Cu2+等对细菌有杀灭作用,且不会或极小可能导致菌株进化。同时研究显示,少量的微量元素掺杂可以提升支架材料的成骨性能和促血管化性能。但低浓度的离子掺杂无法起到足够的抗菌效果,过高浓度的离子掺杂又会对正常组织细胞产生一定的毒性。因此,如何兼顾骨修复材料的抗菌和成骨性能成了困扰研究人员的难题。Postoperative infection is one of the main reasons for the failure of implantation surgery. In the past few decades, the abuse of antibiotics has led to strain mutations, and the number of surgical failures caused by antibiotic resistance has increased year by year. The researchers found that some metal cations, such as Ag + , Mg 2+ , Zn 2+ and Cu 2+ , have a killing effect on bacteria, and will not or minimally lead to strain evolution. At the same time, studies have shown that a small amount of trace element doping can improve the osteogenic and vascularization properties of scaffolds. However, low-concentration ion doping cannot have sufficient antibacterial effect, and high-concentration ion doping will produce certain toxicity to normal tissue cells. Therefore, how to balance the antibacterial and osteogenic properties of bone repair materials has become a difficult problem for researchers.

研究表明,感染多发生在术后早期,造成细菌感染的主要原因一是手术过程中的细菌引入,二是大多数骨修复支架本身容易使细菌定植。因此,若能支架材料本身具备一定的抗菌性能,在植入早期,阻止细菌定植的同时原位杀灭细菌,无疑可以在很大程度上提升手术的成功率。Studies have shown that infection mostly occurs in the early postoperative period, and the main reasons for bacterial infection are firstly the introduction of bacteria during the operation, and secondly, most bone repair scaffolds themselves are prone to bacterial colonization. Therefore, if the stent material itself has certain antibacterial properties, in the early stage of implantation, it can prevent bacterial colonization while killing bacteria in situ, which can undoubtedly improve the success rate of surgery to a large extent.

发明内容SUMMARY OF THE INVENTION

为了解决现有技术中存在的问题,本发明人意识到可以采用交替涂覆两种或多种带有相反电荷的聚合物材料,利用阴阳离子之间的吸附作用,实现一个良好涂覆效果。在此技术的基础上,可以进行多层涂覆,且仍保留支架的多孔结构,同时通过离子交联的方式在不同层掺杂梯度浓度的微量元素,实现在支架植入后的不同时期,释放不同浓度或不同种类的微量元素以满足人体的实际需求。In order to solve the problems existing in the prior art, the inventors realized that two or more polymer materials with opposite charges can be alternately coated, and a good coating effect can be achieved by utilizing the adsorption between anions and cations. On the basis of this technology, multi-layer coating can be carried out, and the porous structure of the scaffold can still be retained, and at the same time, different layers of trace elements can be doped with gradient concentrations by means of ion cross-linking, so as to achieve different periods after stent implantation. Release different concentrations or different kinds of trace elements to meet the actual needs of the human body.

为了实现本发明的目的,本发明的技术方案如下:In order to realize the purpose of the present invention, the technical scheme of the present invention is as follows:

一种具有梯度涂层的骨修复支架的制备方法,包括以下步骤:A preparation method of a bone repair scaffold with gradient coating, comprising the following steps:

步骤1:将光敏树脂、分散剂以及生物陶瓷粉末混合,所述光敏树脂的质量百分比为20%~50%,分散剂的质量百分比为2%~4%,其余组分为生物陶瓷粉末;高速搅拌15min得到混合均匀的浆料;Step 1: Mix the photosensitive resin, dispersant and bioceramic powder, the mass percentage of the photosensitive resin is 20% to 50%, the mass percentage of the dispersant is 2% to 4%, and the remaining components are bioceramic powder; Stir for 15 minutes to obtain a uniformly mixed slurry;

步骤2:将上述步骤1得到的浆料采用3D打印的方式成型为多孔陶瓷坯体,清洗后对陶瓷坯体进行脱脂和高温烧结处理得到多孔支架基体;Step 2: The slurry obtained in the above step 1 is formed into a porous ceramic body by 3D printing, and after cleaning, the ceramic body is subjected to degreasing and high temperature sintering treatment to obtain a porous support matrix;

步骤3:配制涂层溶液,分别配制质量浓度为0.1%~1%的阳离子聚合物溶液和质量浓度为0.1%~1%阴离子聚合物溶液;Step 3: preparing a coating solution, respectively preparing a cationic polymer solution with a mass concentration of 0.1% to 1% and an anionic polymer solution with a mass concentration of 0.1% to 1%;

步骤4:配制金属离子溶液,配制浓度范围为2μmol/L~40μmol/L,且与涂层层数相对应的一系列梯度浓度的金属离子溶液;Step 4: preparing a metal ion solution with a concentration range of 2 μmol/L to 40 μmol/L, and a series of gradient concentration metal ion solutions corresponding to the number of coating layers;

步骤5:将上述步骤2制得的多孔支架,按阳离子聚合物溶液、阴离子聚合物溶液、金属离子溶液的顺序交替浸泡在步骤3和步骤4配制的涂层溶液中;每轮涂覆中,金属离子溶液更换为当前层数对应的溶液;每浸涂一种溶液后,支架需在去离子水中清洗,以去除未吸附的多余溶液,并在50℃的干燥箱中干燥5~10min再进行下一种溶液的浸涂;涂满设定层数后,将支架置于50℃的干燥箱中干燥6~18h,即得所述骨修复支架。Step 5: Alternately soak the porous stent obtained in the above step 2 in the coating solution prepared in step 3 and step 4 in the order of cationic polymer solution, anionic polymer solution, and metal ion solution; in each round of coating, Replace the metal ion solution with the solution corresponding to the current number of layers; after each dip coating of a solution, the stent needs to be washed in deionized water to remove the excess solution that is not adsorbed, and dried in a drying oven at 50 °C for 5 to 10 minutes before proceeding. Dip coating of the next solution; after coating the set number of layers, place the scaffold in a drying oven at 50° C. to dry for 6-18 hours to obtain the bone repair scaffold.

进一步的,所述步骤1中,所述生物陶瓷材料包括氧化锆、氧化铝、磷酸钙、羟基磷灰石、硅酸钙、硅酸镁以及硫酸钙中的一种或多种复合。Further, in the step 1, the bioceramic material includes one or more compounds of zirconia, alumina, calcium phosphate, hydroxyapatite, calcium silicate, magnesium silicate and calcium sulfate.

进一步的,所述步骤2中,考虑到支架脱脂烧结后支架的尺寸收缩以及为涂层涂覆预留空间,选用孔径尺寸为500μm~1500μm的多孔支架模型。Further, in the step 2, considering the size shrinkage of the stent after degreasing and sintering of the stent and the space reserved for coating, a porous stent model with a pore size of 500 μm to 1500 μm is selected.

进一步的,所述步骤3中,所述阳离子性质聚合物可选用壳聚糖、聚二烯丙基二甲基氯化铵(PDDA)、聚赖氨酸(PLL)中的一种或多种,所述阴离子性质聚合物可选用海藻酸钠、透明质酸、聚丙烯酸(PAA)中的一种或多种;所述聚合物材料选用低或中等分子量,以保证适当的粘度,便于将涂层厚度控制在一个较薄的范围;所述聚合物材料均为可降解类型的生物相容性材料。Further, in the step 3, the cationic polymer can be selected from one or more of chitosan, polydiallyldimethylammonium chloride (PDDA), and polylysine (PLL). , the anionic polymer can be selected from one or more of sodium alginate, hyaluronic acid, and polyacrylic acid (PAA); the polymer material is selected from low or medium molecular weight to ensure proper viscosity and facilitate the coating The layer thickness is controlled in a thin range; the polymer materials are all biocompatible materials of degradable type.

进一步的,所述步骤4中,所述金属离子包括钙、镁、锌、铜、锶、铁离子中的一种或多种;作为金属阳离子的配位阴离子可选用氯离子或硝酸根离子。Further, in the step 4, the metal ions include one or more of calcium, magnesium, zinc, copper, strontium, and iron ions; as the coordinating anion of the metal cation, chloride ion or nitrate ion can be selected.

进一步的,所述步骤4中,所述步骤4中配制的一系列梯度浓度溶液,是按照期望的离子释放效果,对各层离子浓度和离子类型进行自由调整的;Further, in the step 4, a series of gradient concentration solutions prepared in the step 4 are free to adjust the ion concentration and ion type of each layer according to the desired ion release effect;

进一步的,所述步骤5中,支架进行第一层第一种聚合物溶液涂覆时,使支架浸泡在聚合物溶液中1~12h,然后在转速为500~1500rmp的离心机中离心5~10min,去除多余溶液,以保证涂层与基体的结合强度;Further, in the step 5, when the stent is coated with the first layer of the first polymer solution, the stent is immersed in the polymer solution for 1 to 12 hours, and then centrifuged in a centrifuge with a rotational speed of 500 to 1500 rmp for 5 to 12 hours. 10min, remove the excess solution to ensure the bonding strength of the coating and the substrate;

进一步的,所述步骤5中,支架在每种溶液中浸泡时间为10~60s;聚合物涂层整体层厚控制在50μrn~200μm,涂覆层数视单层涂层厚度而定;每层涂层包含通过静电作用吸附在一起的阴阳离子性质的聚合物以及以交联形式掺杂在阴离子性质聚合物中的金属阳离子。Further, in the step 5, the stent is soaked in each solution for 10-60s; the overall layer thickness of the polymer coating is controlled at 50μrn-200μm, and the number of coating layers depends on the thickness of the single-layer coating; each layer The coating comprises polymers of anionic and cationic nature adsorbed together by electrostatic interactions and metal cations doped in the polymers of anionic nature in cross-linked form.

与现有技术相比,本发明的有益效果在于:Compared with the prior art, the beneficial effects of the present invention are:

(1)本发明采用的基体材料是生物陶瓷,该种材料拥有广泛的研究基础,并且表现出良好的生物相容性,并且有些材料能够实现降解,降解产物对促进骨修复和骨组织生长有重要作用。(1) The matrix material used in the present invention is a bioceramic, which has a wide research base and exhibits good biocompatibility, and some materials can be degraded, and the degradation products can promote bone repair and bone tissue growth. important role.

(2)本发明采用3D打印技术制备多孔支架,该技术能够根据实际需求生产出适合骨修复孔径大小的支架。此外,使用不同的表面粘附材料,由于其流变性能不同,3D打印技术可以制备出合适的孔径以满足材料的粘附。(2) The present invention adopts the 3D printing technology to prepare the porous scaffold, and the technology can produce the scaffold suitable for the pore size of the bone repair according to the actual needs. In addition, using different surface adhesion materials, due to their different rheological properties, 3D printing technology can prepare suitable pore sizes to meet the adhesion of materials.

(3)本发明通过在多孔陶瓷支架的基础上涂覆掺杂有微量元素的聚合物涂层,使得多孔陶瓷骨修复支架的强度和韧性均得到提高,同时选用聚合物材料均为可降解的生物活性材料,植入人体后不会对细胞产生毒性,也不会引起人体的免疫排斥反应,同时带有聚合物涂层的支架植入人体后,可以产生一定的溶胀,起到稳定支架的作用。(3) In the present invention, the strength and toughness of the porous ceramic bone repair stent are improved by coating the polymer coating doped with trace elements on the basis of the porous ceramic stent, and the selected polymer materials are all degradable Bioactive materials will not be toxic to cells after implantation in the human body, nor will it cause immune rejection in the human body. At the same time, after the stent with polymer coating is implanted into the human body, it can swell to a certain extent, which can stabilize the stent. effect.

(4)本发明通过阳离子性质和阴离子性质聚合物之间的静电吸附作用制备多层结构的聚合物涂层,保证了涂层的稳定性以及与陶瓷基体良好的贴合效果,同时可以将单层涂层厚度控制在一个非常小的数值,在实现多层涂覆的同时保留多孔陶瓷支架的孔隙结构。(4) The present invention prepares the polymer coating of the multilayer structure through the electrostatic adsorption between the cationic and anionic polymers, which ensures the stability of the coating and the good bonding effect with the ceramic substrate, and at the same time, the single The layer coating thickness is controlled to a very small value to achieve multi-layer coating while preserving the pore structure of the porous ceramic scaffold.

(5)本发明通过二价金属阳离子与阴离子性质聚合物中的阴离子基团的交联作用,将具有多功能(多用途)的微量元素掺杂在聚合物材料中,植入体内后随着聚合物的降解逐渐释放,从而实现金属离子的稳定缓慢释放。(5) In the present invention, multi-functional (multi-purpose) trace elements are doped into polymer materials through the cross-linking effect of divalent metal cations and anionic groups in anionic polymers. The degradation of the polymer is gradually released, thereby achieving a stable and slow release of metal ions.

(6)本发明通过在多孔陶瓷支架表面涂覆多层聚合物涂层,聚合物涂层中掺杂具有多功能、多用途的微量元素,通过调控微量元素在各层涂层中的浓度和种类的变化,实现最佳的离子释放效果;例如,通过控制具有抗菌效果的Mg2+、Zn2+、Cu2+等金属离子浓度由外层向内层梯度减少,再配合无抗菌效果的Ca2+保证每层涂层中总的金属离子浓度一定,以减小金属离子浓度变化对聚合物性能的影响,最终实现骨支架植入初期高浓度释放具有抗菌作用的金属离子强化抗菌效果,后期低浓度释放,降低其对细胞的毒性作用,同时刺激细胞成骨。(6) In the present invention, the multi-layer polymer coating is applied on the surface of the porous ceramic stent, and the polymer coating is doped with multi-functional and multi-purpose trace elements. The best ion release effect can be achieved by changing the species; for example, by controlling the concentration of metal ions such as Mg 2+ , Zn 2+ , and Cu 2+ with antibacterial effect from the outer layer to the inner layer, the Ca 2+ ensures that the total metal ion concentration in each coating is constant, so as to reduce the influence of metal ion concentration changes on the properties of the polymer, and finally achieve high-concentration release of metal ions with antibacterial effect in the early stage of bone scaffold implantation to enhance the antibacterial effect. It is released at a low concentration in the later stage, reducing its toxic effect on cells and stimulating osteogenesis of cells at the same time.

附图说明Description of drawings

图1为本发明的制备方法的制备流程图;Fig. 1 is the preparation flow chart of the preparation method of the present invention;

图2为本发明的梯度涂层的结构示意图;Fig. 2 is the structural representation of the gradient coating of the present invention;

图3为本发明的梯度涂层的局部放大示意图;Fig. 3 is the partial enlarged schematic diagram of the gradient coating of the present invention;

图4为本发明实施例1的具有梯度抗菌涂层的多孔支架和MC3T3-E1细胞共同培养7天的细胞生长状态图;4 is a cell growth state diagram of the porous scaffold with gradient antibacterial coating and MC3T3-E1 cells co-cultured for 7 days in Example 1 of the present invention;

图5为本发明实施例1的具有梯度抗菌涂层的多孔支架与没有梯度抗菌涂层的多孔支架的抗菌效果对比图。FIG. 5 is a comparison diagram of the antibacterial effect of the porous stent with the gradient antibacterial coating and the porous stent without the gradient antibacterial coating according to Example 1 of the present invention.

具体实施方式Detailed ways

为了能够更清楚地理解本发明的上述目的、特征和优点,下面将对本发明的方案进一步描述,应理解实施例仅用于说明本发明而不用于限制本发明的范围。In order to more clearly understand the above objects, features and advantages of the present invention, the solution of the present invention will be further described below. It should be understood that the embodiments are only used to illustrate the present invention and not to limit the scope of the present invention.

实施例1:Example 1:

一种具有梯度抗菌涂层的骨修复支架的制备方法,包括以下步骤:A preparation method of a bone repair scaffold with a gradient antibacterial coating, comprising the following steps:

步骤1:将光敏树脂、分散剂以及生物陶瓷粉末混合,所述光敏树脂的质量百分比为50%,分散剂的质量百分比为3%,其余组分为β-磷酸三钙生物陶瓷粉末;在真空搅拌机中已1100rmp的转速高速搅拌15min得到混合均匀的浆料;Step 1: Mix the photosensitive resin, dispersant and bioceramic powder, the mass percentage of the photosensitive resin is 50%, the mass percentage of the dispersant is 3%, and the rest components are β-tricalcium phosphate bioceramic powder; The mixer has been stirred at a high speed of 1100rmp for 15min to obtain a uniformly mixed slurry;

步骤2:将上述步骤1得到的浆料采用DLP光固化成形的方式制备多孔陶瓷坯体;多孔支架模型选用体对角线多孔模型,孔径选用1500μm,选用圆柱状模型,尺寸为直径为9mm,高为4.5mm;将打印获得的陶瓷坯体放入盛有无水乙醇的烧杯中,将烧杯放入超声清洗机清洗5min,以去除多余浆料;之后,用气枪吹去陶瓷表面残留的酒精和浆料,在405nm波长的紫外光下进行二次固化后烘干;最后对陶瓷坯体进行脱脂和高温烧结处理,脱脂曲线为:25~120℃阶段,升温速率0.5℃/min,120℃保温2h;120~360℃阶段,升温速率为0.5℃/min,360℃保温5h;360~420℃阶段,升温速率为0.5℃/min,420℃保温5h;420~510℃阶段,升温速率为0.5℃/min,510℃保温5h;510~900℃阶段,升温速率为0.5℃/min,900℃保温5h;炉冷至室温。烧结曲线为:25~1300℃阶段,升温速率为1℃/min,1300℃保温5h;1300~900℃阶段,降温速率为2℃/min;炉冷至室温。Step 2: Use the slurry obtained in the above step 1 to prepare a porous ceramic body by DLP photocuring; the porous support model is a body diagonal porous model, the aperture is 1500 μm, and a cylindrical model is used, and the size is 9 mm in diameter. The height is 4.5mm; put the printed ceramic body into a beaker filled with absolute ethanol, and put the beaker into an ultrasonic cleaner for 5 minutes to remove excess slurry; after that, use an air gun to blow off the residual alcohol on the ceramic surface And slurry, secondary curing and drying under ultraviolet light of 405nm wavelength; finally, the ceramic body is degreasing and high-temperature sintering. In the stage of 120~360℃, the heating rate is 0.5℃/min, and the temperature is kept at 360℃ for 5h; in the stage of 360~420℃, the heating rate is 0.5℃/min, and the temperature is kept at 420℃ for 5h; in the stage of 420~510℃, the heating rate is 0.5°C/min, hold at 510°C for 5h; in the stage of 510-900°C, the heating rate is 0.5°C/min, hold at 900°C for 5h; furnace cool to room temperature. The sintering curve is as follows: 25~1300℃ stage, heating rate is 1℃/min, 1300℃ hold for 5h; 1300~900℃ stage, cooling rate is 2℃/min; furnace cooled to room temperature.

步骤3:配制涂层溶液,配制质量浓度为0.2%的壳聚糖溶液,溶剂为质量分数为1wt%乙酸溶液,壳聚糖选用脱乙酰度≥95%,粘度在100~200mpa.s之间;配制质量浓度为0.2%海藻酸钠溶液,溶剂为去离子水,海藻酸钠选用分析纯;Step 3: Prepare a coating solution, prepare a chitosan solution with a mass concentration of 0.2%, the solvent is an acetic acid solution with a mass fraction of 1 wt%, the chitosan is selected with a degree of deacetylation ≥ 95%, and the viscosity is between 100-200mpa.s ; The preparation mass concentration is 0.2% sodium alginate solution, the solvent is deionized water, and the sodium alginate is analytically pure;

步骤4:配制ZnCl2和CaCl2混合溶液,溶液A:5μmol/L的ZnCl2和20μmol/L的CaCl2混合溶液;溶液B:15μmol/L的ZnCl2和10μmol/L的CaCl2混合溶液;溶液C:25μmol/L的ZnCl2溶液;溶剂为去离子水。Step 4: prepare a mixed solution of ZnCl 2 and CaCl 2 , solution A: mixed solution of 5 μmol/L ZnCl 2 and 20 μmol/L CaCl 2 ; solution B: mixed solution of 15 μmol/L ZnCl 2 and 10 μmol/L CaCl 2 ; Solution C: 25 μmol/L ZnCl 2 solution; the solvent is deionized water.

步骤5:将上述步骤2制得的多孔支架,在壳聚糖溶液中浸泡12h,然后在转速为1500rmp的离心机中离心5min,放入50℃的干燥箱中干燥5min;然后将支架放入海藻酸钠溶液中浸泡20s,放入50℃的干燥箱中干燥5min;然后将支架放入溶液A中浸泡20s,放入50℃的干燥箱中干燥5min,如此完成第一层涂层的涂覆操作;之后每层涂层的涂覆方式类似,只是在浸泡壳聚糖溶液是只需浸泡20s,且不需离心操作;涂层总层数为24层,内8层浸泡在溶液A中,中间8层浸泡在溶液B中,外8层浸泡在溶液C中;涂覆完成后,将支架只有50℃的干燥箱中干燥12h,即得所述骨修复支架。Step 5: Soak the porous scaffold prepared in the above step 2 in the chitosan solution for 12 hours, then centrifuge it in a centrifuge with a rotation speed of 1500 rpm for 5 minutes, and put it into a drying box at 50 °C for 5 minutes; then put the scaffold into Soak in sodium alginate solution for 20s, put it in a drying oven at 50°C for 5min; then put the stent in solution A, soak it for 20s, put it in a drying oven at 50°C for 5min, and complete the coating of the first layer. After that, the coating method of each layer is similar, except that the chitosan solution only needs to be soaked for 20s, and no centrifugal operation is required; the total number of layers of the coating is 24 layers, and the inner 8 layers are soaked in solution A. , the middle 8 layers were immersed in solution B, and the outer 8 layers were immersed in solution C; after the coating was completed, the scaffold was dried in a drying oven at 50° C. for 12 hours to obtain the bone repair scaffold.

将上述步骤得到的带有梯度抗菌涂层的骨修复支架以120℃的温度进行高温灭菌处理,然后将支架放入24孔细胞培养板内,每孔加入MC3T3-E1细胞浓度为104个/mL的细胞培养基1mL,将24孔板放入温度为37℃,CO2含量为5%的细胞培养箱进行培养,培养时间为7天,过程中每两天用PBS清洗后更换一次培养基,如图4所示,为细胞培养7天后,在光学显微镜下,支架表现出良好的生长状态和粘附效果。The bone repair scaffold with gradient antibacterial coating obtained in the above steps was subjected to high temperature sterilization at a temperature of 120 ° C, and then the scaffold was placed in a 24-well cell culture plate, and MC3T3-E1 cells were added to each well at a concentration of 104 cells/well. 1mL of cell culture medium, put the 24-well plate into a cell incubator with a temperature of 37 °C and a CO content of 5% for 7 days, and the culture medium was replaced every two days after washing with PBS. , as shown in Figure 4, after 7 days of cell culture, under the light microscope, the scaffolds showed a good growth state and adhesion effect.

将100μL细菌浓度为106CFU/mL的大肠杆菌菌液接种到上述步骤得到的带有梯度抗菌涂层的骨修复支架表面(菌液采用PBS稀释),在37℃下培养2小时,然后将支架放入30mL的PBS溶液中充分震荡后,从中取100μL均匀涂布在固体琼脂培养基表面,置于37℃的细菌培养箱中培养24小时,观察菌落生长情况,选择无涂层的支架作为对照组,相同操作,如图5所示,为具有梯度抗菌涂层的多孔支架与没有梯度抗菌涂层的多孔支架的抗菌效果对比图。Inoculate 100 μL of Escherichia coli bacterial solution with a bacterial concentration of 10 6 CFU/mL on the surface of the bone repair scaffold with a gradient antibacterial coating obtained in the above step (the bacterial solution is diluted with PBS), cultured at 37 ° C for 2 hours, and then inoculated. After the scaffold was fully shaken in 30 mL of PBS solution, 100 μL was taken from it and spread evenly on the surface of the solid agar medium, placed in a bacterial incubator at 37 °C for 24 hours, and the colony growth was observed, and an uncoated scaffold was selected as the The control group, the same operation, as shown in Figure 5, is a comparison diagram of the antibacterial effect of the porous scaffold with the gradient antibacterial coating and the porous scaffold without the gradient antibacterial coating.

对实施例1中得到的具有梯度抗菌涂层的骨修复支架进行细胞相容性和抗菌性能测试,测试结果如图3和图4所示,测试结果表明,通过在多孔陶瓷支架上多层涂覆掺有少量锌离子的聚合物涂层,可以实现使支架拥有抗菌效果的同时几乎不对细胞产生毒性作用。The cytocompatibility and antibacterial properties of the bone repair scaffold with gradient antibacterial coating obtained in Example 1 were tested. The test results are shown in Figure 3 and Figure 4. A polymer coating doped with a small amount of zinc ions can achieve an antibacterial effect on the stent with little toxicity to cells.

以上仅为本发明的优选实施例,但本发明的技术特征并不局限于此。应当指出,任何以本发明为基础,为实现基本相同的技术效果,所做出的简单变化、等同替换等,皆涵盖于本发明的保护范围之内。The above are only preferred embodiments of the present invention, but the technical features of the present invention are not limited thereto. It should be pointed out that any simple changes, equivalent replacements, etc. made based on the present invention in order to achieve basically the same technical effect are all covered within the protection scope of the present invention.

Claims (8)

1. A preparation method of a bone repair scaffold with a gradient coating is characterized by comprising the following steps:
step 1: mixing photosensitive resin, a dispersing agent and biological ceramic powder, wherein the mass percent of the photosensitive resin is 20-50%, the mass percent of the dispersing agent is 2-4%, and the rest components are the biological ceramic powder; stirring at high speed for 15min to obtain uniformly mixed slurry;
step 2: forming the slurry obtained in the step 1 into a porous ceramic blank by adopting a 3D printing mode, and degreasing and sintering the ceramic blank at a high temperature after cleaning;
and 3, step 3: preparing a coating solution, namely respectively preparing a cationic polymer solution with the mass concentration of 0.1-1% and an anionic polymer solution with the mass concentration of 0.1-1%;
and 4, step 4: preparing a metal ion solution, wherein the metal ion solution with a concentration range of 2-40 mu mol/L and a series of gradient concentrations corresponding to the number of coating layers is prepared;
and 5: alternately soaking the porous scaffold prepared in the step 2 in the coating solution prepared in the step 3 and the step 4 according to the sequence of the cationic polymer solution, the anionic polymer solution and the metal ion solution; in each round of coating, the metal ion solution is replaced by a solution corresponding to the current layer number; after each solution is dip-coated, the bracket needs to be cleaned in deionized water to remove the unadsorbed redundant solution, and is dried in a drying oven at 50 ℃ for 5-10 min before the next solution is dip-coated; and after the set number of layers is fully coated, placing the scaffold in a drying box at 50 ℃ for drying for 6-18 h to obtain the bone repair scaffold.
2. The method according to claim 1, wherein the bioceramic material in step 1 comprises one or more of zirconia, alumina, calcium phosphate, hydroxyapatite, calcium silicate, magnesium silicate and calcium sulfate.
3. The method according to claim 1, wherein the porous scaffold model used in step 2 has a pore size of 500 to 1500 μm.
4. The preparation method of claim 1, wherein the cationic polymer in step 2 is one or more selected from chitosan, poly (diallyldimethylammonium chloride) (PDDA) and Polylysine (PLL), and the anionic polymer is one or more selected from sodium alginate, hyaluronic Acid (HA) and polyacrylic acid (PAA); the polymer materials are all degradable type biocompatible materials.
5. The preparation method according to claim 1, wherein the metal ions in step 4 comprise one or more of calcium, magnesium, zinc, copper, strontium and iron ions; as coordinating anion of the metal cation, chloride or nitrate may be used.
6. The method of claim 1, wherein the ion concentration and ion type of each layer are freely adjusted according to the desired ion release effect in the series of gradient concentration solutions prepared in step 4.
7. The method according to claim 1, wherein the coating of the first polymer solution on the stent in step 5 is performed by immersing the stent in the polymer solution for 1 to 12 hours and then centrifuging the stent in a centrifuge at a rotation speed of 500 to 1500rmp for 5 to 10 minutes to remove the excess solution.
8. The method according to claim 1, wherein the soaking time of the stent in each solution in the step 5 is 10 to 60s; the overall layer thickness of the polymer coating is controlled to be 50-200 mu m, and the number of the coating layers depends on the thickness of a single-layer coating.
CN202210039664.3A 2022-01-13 2022-01-13 Bone repair stent with gradient coating and preparation method thereof Pending CN115212354A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210039664.3A CN115212354A (en) 2022-01-13 2022-01-13 Bone repair stent with gradient coating and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210039664.3A CN115212354A (en) 2022-01-13 2022-01-13 Bone repair stent with gradient coating and preparation method thereof

Publications (1)

Publication Number Publication Date
CN115212354A true CN115212354A (en) 2022-10-21

Family

ID=83606838

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210039664.3A Pending CN115212354A (en) 2022-01-13 2022-01-13 Bone repair stent with gradient coating and preparation method thereof

Country Status (1)

Country Link
CN (1) CN115212354A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115746482A (en) * 2022-11-02 2023-03-07 浙江大学杭州国际科创中心 Method for preparing porous material through 3D printing

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876742A (en) * 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US20110153006A1 (en) * 2009-12-21 2011-06-23 Laura Sager Biocorrodible implants having a functionalized coating
CN108144119A (en) * 2018-01-12 2018-06-12 郑州大学 A kind of method that antibacterial Sodium Hyaluronate and chitosan bilayer are prepared on Biological magnesium alloy surface apatite coating
CN108379658A (en) * 2018-02-06 2018-08-10 中国科学院金属研究所 With the orthopaedics implant devices and preparation method thereof containing copper coating
CN109650909A (en) * 2019-02-20 2019-04-19 四川大学 A kind of calcium phosphate bone induction bioceramic scaffold and preparation method thereof based on photocuring 3D printing technique
WO2021046615A1 (en) * 2019-09-12 2021-03-18 The University Of Sydney Compositions and method of printing ceramic materials
CN112773944A (en) * 2020-11-24 2021-05-11 季华实验室 Bone repair stent with microelement-loaded coating and preparation method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876742A (en) * 1994-01-24 1999-03-02 The Regents Of The University Of California Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof
US20110153006A1 (en) * 2009-12-21 2011-06-23 Laura Sager Biocorrodible implants having a functionalized coating
CN108144119A (en) * 2018-01-12 2018-06-12 郑州大学 A kind of method that antibacterial Sodium Hyaluronate and chitosan bilayer are prepared on Biological magnesium alloy surface apatite coating
CN108379658A (en) * 2018-02-06 2018-08-10 中国科学院金属研究所 With the orthopaedics implant devices and preparation method thereof containing copper coating
CN109650909A (en) * 2019-02-20 2019-04-19 四川大学 A kind of calcium phosphate bone induction bioceramic scaffold and preparation method thereof based on photocuring 3D printing technique
WO2021046615A1 (en) * 2019-09-12 2021-03-18 The University Of Sydney Compositions and method of printing ceramic materials
CN112773944A (en) * 2020-11-24 2021-05-11 季华实验室 Bone repair stent with microelement-loaded coating and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OHAN S. MANOUKIAN,ET AL.: "Spiral Layer-by-Layer Micro-Nanostructured Scaffolds for Bone Tissue Engineering", 《ACS BIOMATERIALS SCIENCE & ENGINEERING》 *
顾嘉骏等: "基于光固化的羟基磷灰石3D打印工艺研究", 《航空制造技术》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115746482A (en) * 2022-11-02 2023-03-07 浙江大学杭州国际科创中心 Method for preparing porous material through 3D printing
CN115746482B (en) * 2022-11-02 2024-03-22 浙江大学杭州国际科创中心 Method for preparing porous material by 3D printing

Similar Documents

Publication Publication Date Title
CN100421736C (en) A kind of laminated gradient composite scaffold material based on bionic structure and its preparation method
Wu et al. 3D printed chitosan-gelatine hydrogel coating on titanium alloy surface as biological fixation interface of artificial joint prosthesis
CN111070376A (en) 3D printing bionic porous bioceramic artificial bone and preparation method thereof
Li et al. Preparation and characterization of PHBV microsphere/45S5 bioactive glass composite scaffolds with vancomycin releasing function
CN113262325B (en) A 3D printing custom-programmed specific biological function to promote bone tissue repair and regeneration scaffold material and preparation method thereof
Kargozar et al. Synergistic combination of bioactive glasses and polymers for enhanced bone tissue regeneration
Rowe et al. Dimensionally stable and bioactive membrane for guided bone regeneration: An in vitro study
CN1586636A (en) Method for compounding aquo-gel to porous tissue engineering rack
Jeong et al. 3D printing of bone‐mimetic scaffold composed of gelatin/β‐tri‐calcium phosphate for bone tissue engineering
CN109966547A (en) 3D printing bone tissue engineering scaffold with slow-release antibacterial function and preparation method
CN1887365A (en) Biological material film with porous structure and its prepn
RU2756164C2 (en) Nano-composite layer based on collagen nano-fibers and its production method
Ghorbani et al. Immobilization of gelatin on the oxygen plasma-modified surface of polycaprolactone scaffolds with tunable pore structure for skin tissue engineering
CN114588312B (en) Functionalized fiber macromolecular cross-linked body bonded 3D printed elastic implant and its preparation method and application
Jiang et al. Antibacterial nanohydroxyapatite/polyurethane composite scaffolds with silver phosphate particles for bone regeneration
He et al. Enhanced bone regeneration using poly (trimethylene carbonate)/vancomycin hydrochloride porous microsphere scaffolds in presence of the silane coupling agent modified hydroxyapatite nanoparticles
CN101474428A (en) Polyester reinforced degradable porous gastrosil compound stent material, preparation and use
CN102008753B (en) Organic-inorganic composite gel material for bone repair and preparation method thereof
CN114538914A (en) Zinc-doped calcium phosphate ceramic microsphere with antibacterial function and preparation method thereof
CN115212354A (en) Bone repair stent with gradient coating and preparation method thereof
Xie Bio‐inspired nanofunctionalisation of biomaterial surfaces: a review
Hu et al. 3D printed polyetheretherketone bone tissue substitute modified via amoxicillin-laden hydroxyapatite nanocoating
CN110734646A (en) Preparation method of COL/PEG @ CaP biomineralization multilayer film
CN108578780B (en) A kind of preparation method of artificial bone scaffold with silver ion and mechanical gradient
Jang et al. Mastoid obliteration using three‐dimensional composite scaffolds consisting of polycaprolactone/β‐tricalcium phosphate/collagen nanofibers: an in vitro and in vivo study

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20240806

AD01 Patent right deemed abandoned